The healthcare world is excited by the potential of GLP-1 transdermal systems . Currently, GLP-1 receptor agonists are primarily administered via injection , which can be a challenge for some patients . These https://www.bigdaishowa.eu/sites/detail/?p=Microdosing-Tirzepatide-Chart--Safe-Dosage-Ranges-Explained-ACcyWNm2xbpaa